Madeleine Combet Epse Broll

Title: The Innovative Contributions of Madeleine Combet Epse Broll

Introduction

Madeleine Combet Epse Broll is a notable inventor based in St. Egreve, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating anxiety and aggressivity. Her work exemplifies the intersection of scientific research and practical application in medicine.

Latest Patents

Madeleine holds a patent for "Urea derivatives to treat anxiety and aggressivity." This patent includes urea derivatives of the formula: ##STR1## wherein R.sub.1, R.sub.2, and R.sub.3, which are the same or different, each represent a straight- or branched-chain alkyl, alkenyl, or alkynyl radical having from 1 to 5 carbon atoms. Additionally, R.sub.4 and R.sub.5, which are the same or different, each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl, or alkynyl radical having from 1 to 5 carbon atoms. This innovative approach highlights her commitment to addressing mental health issues through chemical solutions.

Career Highlights

Throughout her career, Madeleine has demonstrated a strong dedication to research and innovation. Her work has not only contributed to her field but has also paved the way for future advancements in the treatment of psychological conditions. With a total of 1 patent, she continues to be a driving force in her area of expertise.

Collaborations

Madeleine has collaborated with esteemed colleagues such as Charles Pigerol and Pierre Luc Eymard. These partnerships have allowed her to enhance her research and expand the impact of her inventions.

Conclusion

Madeleine Combet Epse Broll is a pioneering inventor whose work in developing urea derivatives for treating anxiety and aggressivity showcases her innovative spirit. Her contributions to the field of pharmaceuticals are invaluable and reflect her commitment to improving mental health treatments.